Quanterix (QTRX) Expected to Announce Quarterly Earnings on Monday

Quanterix (NASDAQ:QTRX) is expected to announce its Q4 2025 results after the market closes on Monday, March 2nd. Analysts expect the company to announce earnings of ($0.27) per share and revenue of $37.9520 million for the quarter. Parties are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Monday, March 2, 2026 at 4:30 PM ET.

Quanterix Stock Performance

Shares of QTRX opened at $5.67 on Tuesday. The company has a 50-day simple moving average of $6.57 and a 200-day simple moving average of $5.95. Quanterix has a 52 week low of $4.05 and a 52 week high of $8.77. The firm has a market capitalization of $264.85 million, a P/E ratio of -2.43 and a beta of 1.09.

Analysts Set New Price Targets

Several research firms have commented on QTRX. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Quanterix in a report on Thursday, January 22nd. Wall Street Zen upgraded Quanterix from a “sell” rating to a “hold” rating in a research report on Monday, December 29th. Finally, Canaccord Genuity Group raised their target price on Quanterix from $5.00 to $8.00 and gave the stock a “hold” rating in a research report on Monday, December 22nd. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $11.33.

Hedge Funds Weigh In On Quanterix

Hedge funds and other institutional investors have recently modified their holdings of the stock. Caitong International Asset Management Co. Ltd acquired a new stake in Quanterix in the 4th quarter valued at $27,000. Quarry LP boosted its stake in shares of Quanterix by 277,300.0% in the 3rd quarter. Quarry LP now owns 5,548 shares of the company’s stock valued at $30,000 after purchasing an additional 5,546 shares in the last quarter. Renaissance Technologies LLC bought a new stake in shares of Quanterix in the 4th quarter worth about $75,000. HUB Investment Partners LLC acquired a new stake in shares of Quanterix during the 2nd quarter worth about $81,000. Finally, HRT Financial LP acquired a new stake in shares of Quanterix during the 4th quarter worth about $82,000. Institutional investors own 86.48% of the company’s stock.

Quanterix Company Profile

Quanterix Corporation is a life sciences and diagnostics company specializing in ultra-sensitive digital immunoassay platforms. Its proprietary Single Molecule Array (Simoa) technology enables researchers to detect and quantify proteins, peptides and nucleic acids at femtomolar concentrations, offering sensitivity that surpasses traditional immunoassay methods. By translating single-molecule detection into routine laboratory workflows, Quanterix aims to accelerate biomarker discovery and the development of novel diagnostics and therapeutics.

The company’s core product portfolio includes the Simoa HD-1 and HD-X Analyzers, which automate high-throughput digital immunoassays for quantifying low-abundance biomarkers.